| Abnormal uterine bleeding | 91, 97 |
| Adenomyosis | 312 |
| Aging women | 319 |
| Anatomy | 253 |
| Anti-incontinence surgery | 8 |
| Anti-phospholipid antibody syndrome | 85 |
| Aortacaval zone | 259 |
| Aromatase inhibitor | 132 |
| Assisted reproduction | 235 |
| Assisted reproductive techniques | 279 |
| AUB | 91 |
| Autologus | 168 |
| Autonomous surgery | 58 |
| Blastocyst | 120 |
| Bologna criteria | 47 |
| Breast | 107 |
| CA125 | 161 |
| Cadaveric | 332 |
| Cancer | 253 |
| Cardiovascular risk | 319 |
| Catechol estrogen | 42 |
| Cervical cancer | 242, 255 |
| Cervical cerclage | 22 |
| Cervical glands | 1 |
| Cervical insufficiency | 22 |
| Cervical mass | 153 |
| Cervical stump | 153 |
| Chest radiography | 196 |
| Chromium | 187 |
| Clinical pregnancy rate | 279 |
| Clomiphene citrate | 132 |
| CML | 127 |
| Computed tomography | 196 |
| COMT Val158Met polymorphism | 42 |
| Controlled ovarian hyperstimulation | 293 |
| Cord blood | 187 |
| COVID-19 | 8, 196 |
| Data collection | 235 |
| Deep infiltrating endometriosis | 312 |
| Dermoid cyst | 336 |
| Diabetes | 319 |
| Diagnosis | 161 |
| Diagnostic hysteroscopy | 206 |
| Dietary supplement | 217 |
| Dissection | 155 |
| Dominant follicle | 132 |
| Doppler | 300 |
| Ductus venosus | 300 |
| Dydrogesterone | 293 |
| Dyspareunia | 112 |
| Dysuria | 112 |
| Ectopic pregnancy | 257 |
| Education | 253 |
| Embryo transfer day | 279 |
| Embryonic developmental arrest | 181 |
| Endometrial ablation | 97 |
| Endometrial adenocarcinoma | 262 |
| Endometrial cancer | 161, 242, 319 |
| Endometrial glands | 1 |
| Endometrial scratching | 47 |
| Endometriosis | 336 |
| Endometrium | 80 |
| Endosalpingiosis | 336 |
| Endothelial dysfunction | 29 |
| Essure | 83 |
| Etiology | 139 |
| Expression analysis | 273 |
| Female pelvic medicine | 8 |
| Fertility-sparing surgery | 255 |
| Fibroid uterus | 80 |
| Flap | 332 |
| Fresh embryo transfer | 206 |
| Frozen-thawed embryo transfer | 206 |
| Gestational diabetes | 217 |
| Gestational diabetes mellitus | 127 |
| GFAAS | 187 |
| Giant lymph node | 259 |
| GM-CSF | 181 |
| GnRH antagonist protocol | 47 |
| Groin | 155 |
| Growing teratoma syndrome | 158 |
| HE4 | 161 |
| Hematuria | 112 |
| Hsa-miR-517a/b | 273 |
| Hypertension | 29 |
| Hypogastric nerve | 255 |
| Hysterectomy | 53, 76 |
| ICSI | 47, 120, 181 |
| Impaired glucose intolerance | 127 |
| Implantation | 29 |
| In-vitro fertilization | 206 |
| Infertility | 312 |
| Inguinofemoral | 155 |
| Ins/Del | 268 |
| Interstitial pregnancy | 257 |
| Isolated oligohydramnios | 286 |
| IVF | 235 |
| Laparoendoscopic single site surgery | 76 |
| Laparoscopic hysterectomy | 76 |
| Laparoscopic radical trachelectomy | 255 |
| Laparoscopic surgery | 53, 312 |
| Laparoscopic surgery | 53 |
| Laparoscopy | 76, 83, 153, 158, 257, 259, 329, 336 |
| LESS | 76 |
| Less radical surgery | 37 |
| Low-risk cervical cancer | 37 |
| Luteinizing hormone surge | 293 |
| Lymphadenectomy | 155, 253 |
| Lymphadenopathy | 107 |
| Machine learning | 58 |
| Mammography | 107 |
| Management | 158 |
| Maternal blood | 187 |
| Menopause | 319 |
| Metabolic syndrome | 319 |
| microRNAs | 273 |
| Minimal invaziv surgery | 257 |
| Minimally invasive surgery | 174 |
| Morbidity | 12 |
| Morcellation | 53 |
| MPN | 120 |
| MR spectroscopy | 132 |
| Multicompartmental prolapse | 174 |
| Multiple pregnancy rates | 168 |
| MultiPN | 120 |
| Myocardial performance index | 286 |
| Myoma | 91 |
| Myomectomy | 312 |
| Myomectomy | 53 |
| Near miss healthcare | 12 |
| Nerve-sparing surger | 255 |
| Neutrophil-lymphocyte ratio | 22 |
| Nickel | 187 |
| Oocyte vitrification | 168 |
| Open surgery | 312 |
| Ovarian cancer | 42, 242 |
| Ovulation induction | 279 |
| PALM-COEIN | 91 |
| Parametrial invasion | 37 |
| Pelvic organ prolapse | 174 |
| Perinatal care | 12 |
| Perinatal outcome | 286 |
| Perineum | 332 |
| Placenta | 187, 273 |
| Placental growth factor | 212 |
| Polycystic ovary syndrome | 319 |
| Polymorphism | 268 |
| Polyp | 91 |
| Poor ovarian response | 47 |
| Preeclampsia | 85, 212, 268, 273 |
| Pregnancy | 196 |
| Pregnancy rate | 206 |
| Premenstrual dysphoric disorder | 139 |
| Premenstrual syndrome | 139 |
| Preoperative diagnosis | 312 |
| Preterm | 286 |
| Preterm birth | 22 |
| Preterm delivery | 85 |
| Progestin-primed ovarian stimulation | 293 |
| Prognosis | 262 |
| Prolapse surgery | 8 |
| Radiology | 196 |
| RAGE/AGER | 127 |
| Rectopexy | 174 |
| Recurrence | 262 |
| Recurrent IVF failure | 181 |
| Reference range | 187 |
| Renal artery Doppler | 286 |
| rFSH | 132 |
| Robot-assisted surgery | 312 |
| Robotic | 80, 329 |
| Robotic hysterectomy | 76 |
| Robotic surgery | 58 |
| Sacrocolpopexy | 174 |
| Salpingectomy | 83 |
| Sapporo’s criteria | 85 |
| Screening | 85 |
| Sentinel lymph node | 242 |
| Severe pre-eclampsia | 29 |
| Single embryo transfer | 168 |
| Single port | 76, 329 |
| Skill analysis | 58 |
| Skill learning | 58 |
| Soluble endoglin | 212 |
| Soluble fms-like tyrosine kinase 1 | 212 |
| Spotting | 1 |
| Superoxide dismutase | 268 |
| Supracervical | 97 |
| Supracervical hysterectomy | 1, 97 |
| Surgery | 253 |
| Surgical procedures | 80 |
| Surgical technique | 83 |
| Survival | 262 |
| Susceptibility | 268 |
| Systematic review | 97 |
| Telemedicine | 8 |
| Time-lapse | 120 |
| Tissue | 161 |
| Trachelectomy | 329 |
| Transvaginal ultrasound | 312 |
| Treatment | 139 |
| Trophoblast | 29 |
| Tuberculosis | 107 |
| Twin pregnancy | 12 |
| Two port | 329 |
| Ultrasonography | 107, 300 |
| Unicenteric castleman disease | 259 |
| Urinary tract endometriosis | 112 |
| Uterine cavity | 206 |
| Uterine isthmus | 1 |
| Vaginal surgery | 53 |
| Validation | 187 |
| Vitamin D | 217 |
| Vulvar cancer | 155, 242, 332 |
| Vulvectomy | 332 |